Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imdelltra
Pharma
ESMO: Amgen’s Imdelltra stages Rasonque-like moment in SCLC
When added on top of AstraZeneca’s Imfinzi, Imdelltra reduced the risk of death by 58% as a first-line maintenance therapy in extensive-stage SCLC.
Angus Liu
Oct 24, 2026 10:30am
Amgen’s Imdelltra scores overall survival win in first-line SCLC
Sep 8, 2026 11:42am
BeOne bags $885M in Royalty deal on Amgen's Imdelltra
Aug 25, 2025 10:34am
ASCO: Amgen's Imdelltra prolongs life in small cell lung cancer
Jun 2, 2025 8:00am
ASCO: Roche, Jazz lung cancer win leaves room for improvement
May 22, 2025 5:00pm
Amgen touts phase 3 survival win for lung cancer drug Imdelltra
Apr 11, 2025 2:43pm
